OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager

OSE Immunotherapeutics SA

PAR:OSE

Watchlist

Dividends

Discount Rate

Price: 8.89 EUR 2.42% Market Closed

Market Cap: 193.4m EUR

Have any thoughts about
OSE Immunotherapeutics SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 8.89 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

OSE Alert

OSE Immunotherapeutics SA

8.89

+0.21 (+2.42%)

52 Week Range	3.2 10.74
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

OSE Immunotherapeutics SA

What unique competitive advantages
does OSE Immunotherapeutics SA hold over its rivals?

What risks and challenges
does OSE Immunotherapeutics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of OSE Immunotherapeutics SA.

What unique competitive advantages
does OSE Immunotherapeutics SA hold over its rivals?

What risks and challenges
does OSE Immunotherapeutics SA face in the near future?

Has there been any significant insider trading activity
in OSE Immunotherapeutics SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for OSE Immunotherapeutics SA.

Provide P/S
for OSE Immunotherapeutics SA.

Provide P/E
for OSE Immunotherapeutics SA.

Provide P/OCF
for OSE Immunotherapeutics SA.

Provide P/FCFE
for OSE Immunotherapeutics SA.

Provide P/B
for OSE Immunotherapeutics SA.

Provide EV/S
for OSE Immunotherapeutics SA.

Provide EV/GP
for OSE Immunotherapeutics SA.

Provide EV/EBITDA
for OSE Immunotherapeutics SA.

Provide EV/EBIT
for OSE Immunotherapeutics SA.

Provide EV/OCF
for OSE Immunotherapeutics SA.

Provide EV/FCFF
for OSE Immunotherapeutics SA.

Provide EV/IC
for OSE Immunotherapeutics SA.

Show me price targets
for OSE Immunotherapeutics SA made by professional analysts.

What are the Revenue projections
for OSE Immunotherapeutics SA?

How accurate were the past Revenue estimates
for OSE Immunotherapeutics SA?

What are the Net Income projections
for OSE Immunotherapeutics SA?

How accurate were the past Net Income estimates
for OSE Immunotherapeutics SA?

What are the EPS projections
for OSE Immunotherapeutics SA?

How accurate were the past EPS estimates
for OSE Immunotherapeutics SA?

What are the EBIT projections
for OSE Immunotherapeutics SA?

How accurate were the past EBIT estimates
for OSE Immunotherapeutics SA?

Compare the revenue forecasts
for OSE Immunotherapeutics SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of OSE Immunotherapeutics SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of OSE Immunotherapeutics SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of OSE Immunotherapeutics SA compared to its peers.

Compare the P/E ratios
of OSE Immunotherapeutics SA against its peers.

Discuss the investment returns and shareholder value creation
comparing OSE Immunotherapeutics SA with its peers.

Analyze the financial leverage
of OSE Immunotherapeutics SA compared to its main competitors.

Show all profitability ratios
for OSE Immunotherapeutics SA.

Provide ROE
for OSE Immunotherapeutics SA.

Provide ROA
for OSE Immunotherapeutics SA.

Provide ROIC
for OSE Immunotherapeutics SA.

Provide ROCE
for OSE Immunotherapeutics SA.

Provide Gross Margin
for OSE Immunotherapeutics SA.

Provide Operating Margin
for OSE Immunotherapeutics SA.

Provide Net Margin
for OSE Immunotherapeutics SA.

Provide FCF Margin
for OSE Immunotherapeutics SA.

Show all solvency ratios
for OSE Immunotherapeutics SA.

Provide D/E Ratio
for OSE Immunotherapeutics SA.

Provide D/A Ratio
for OSE Immunotherapeutics SA.

Provide Interest Coverage Ratio
for OSE Immunotherapeutics SA.

Provide Altman Z-Score Ratio
for OSE Immunotherapeutics SA.

Provide Quick Ratio
for OSE Immunotherapeutics SA.

Provide Current Ratio
for OSE Immunotherapeutics SA.

Provide Cash Ratio
for OSE Immunotherapeutics SA.

What is the historical Revenue growth
over the last 5 years for OSE Immunotherapeutics SA?

What is the historical Net Income growth
over the last 5 years for OSE Immunotherapeutics SA?

What is the current Free Cash Flow
of OSE Immunotherapeutics SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for OSE Immunotherapeutics SA.

P/B
Price to Book Value

2.4

Current

2.9

Median

2.5

Industry

Lower than median

Lower than industry value

Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.

P/B

2.4

Market Cap

193.5m EUR

Book Value of Equity

81.4m EUR

All Countries

Forward Multiples

			Market Cap	P/B
FR		OSE Immunotherapeutics SA PAR:OSE	193.5m EUR	2.4
FR		Pharnext SCA OTC:PNEXF	6T USD	-186 195.9
US		Abbvie Inc NYSE:ABBV	312.7B USD	51.8
US		Amgen Inc NASDAQ:AMGN	158.3B USD	21
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	116.2B USD	7.4
US		Gilead Sciences Inc NASDAQ:GILD	112.4B USD	6.1
US	E	Epizyme Inc F:EPE	94.1B EUR	-4 835
AU		CSL Ltd ASX:CSL	133.6B AUD	5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	81.3B USD	2.8
US	S	Seagen Inc F:SGT	39.3B EUR	16.1
NL		argenx SE XBRU:ARGX	34.8B EUR	8.5


FR		OSE Immunotherapeutics SA PAR:OSE	Average P/B: 13.5 2.4
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -186 195.9
US		Abbvie Inc NYSE:ABBV	51.8
US		Amgen Inc NASDAQ:AMGN	21
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	7.4
US		Gilead Sciences Inc NASDAQ:GILD	6.1
US	E	Epizyme Inc F:EPE	Negative Multiple: -4 835
AU		CSL Ltd ASX:CSL	5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	2.8
US	S	Seagen Inc F:SGT	16.1
NL		argenx SE XBRU:ARGX	8.5

P/B Forward Multiples

Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/B

N/A

2-Years Forward

P/B

N/A

3-Years Forward

P/B

N/A

OSE Immunotherapeutics SA
PAR:OSE

P/B
Price to Book Value

P/B Forward Multiples

See Also

Company

Help

Tools

Stocks

OSE Immunotherapeutics SA PAR:OSE

P/B Price to Book Value

P/B Forward Multiples

See Also

Company

Help

Tools

Stocks

OSE Immunotherapeutics SA
PAR:OSE

P/B
Price to Book Value